Trident Bioscience Analysis: $150K Raised
What is Trident Bioscience?
Trident Bioscience develops a machine learning operations platform for biotechnology, enhancing model deployment and collaboration among scientists and engineers.
Employees
1
Founded
2020
Revenue
$947K
Investors
- Y Combinator
Product Features & Capabilities
- Trident Chemwidgets, machine learning operations (MLOps) platform, predictive models for protein discovery, tools for biochemical data input and analysis, optimization of useful proteins.
How much Trident Bioscience raised
Seed - $150,000
August 25, 2020Lead Investor: Y Combinator
Who are the founders of Trident Bioscience
TS
Tyler Shimko
Founder
Market Focus
Trident Bioscience primarily focuses on the biotechnology industry, specifically developing a machine learning operations (MLOps) platform that integrates biochemical data with machine learning processes.
Competitors Overview
Trident Bioscience operates in the biotechnology sector, focusing on machine learning operations (MLOps) for integrating biochemical data. Its main competitors include:
- Insilico Medicine: This company develops technologies to accelerate drug discovery and development, aiming to extend health
See something that needs updating? Suggest edits to this profile.